Please login to the form below

Not currently logged in
Email:
Password:

Edelman strengthens healthcare team

Appoints Vicky Bramham, Louise Daltan and Emma Coughlan
Edelman Louise, Emma and Vicky

From left: Louise Daltan, Emma Coughlan, Vicky Bramham

Global communications firm Edelman has appointed three senior health communications specialists to strengthen its healthcare team.

Formerly a director at Virgo Health, Vicky Bramham joins Edelman's London branch, taking up the position of director of health brands at the agency.

Bramham brings 15 years of healthcare communications expertise to the role, with particular experience in oncology, respiratory and mental health therapy areas. She will lead the health brands team's global and EU business, specialising in European media strategy.

Prior to joining UK medical communications agency Virgo Health in 2013, Bramham served as a senior consultant at Chandler Chicco Agency.

Also joining Edelman's London office are Louise Dalton and Emma Coughlan, with both becoming associate directors in the healthcare team.

Dalton moves to the agency from Blue Rubicon, where she was a senior consultant, and also brings experience from Ogilvy & Mather and Weber Shandwick, where she most recently served as an account director.

Meanwhile, Coughlan brings 10 years of industry experience to Edelman and joins the agency from Tonic Life, where she spent three years as a senior account director.

Edelman's managing director of health brands Ann Bartling, said: “I am pleased to have three talented health communicators join Edelman, bringing new energy, experience and insight to our expanding offering.

“Our healthcare services has grown significantly over the last several years, and Vicky, Louise and Emma position us well to continue to bring strong and creative counsel to our clients.”

3rd October 2016

From: Marketing

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Conversis

Conversis is a translation company specialising in translation and localisation for the Life Science and Pharmaceutical industry, with particular focus...

Latest intelligence

Where next in Alzheimer’s disease R&D?
How past failures and emerging biology are reshaping drug development...
Brain scan
Brain power: fresh approaches to Alzheimer’s drug discovery
New alliances are learning from past mistakes and breaking down research barriers...
Genomics integration: can the NHS rise to the challenge?
Experts gather to discuss the UK’s genomic landscape...

Infographics